1. Home
  2. GKOS vs FRO Comparison

GKOS vs FRO Comparison

Compare GKOS & FRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$116.08

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Logo Frontline Plc

FRO

Frontline Plc

HOLD

Current Price

$21.70

Market Cap

5.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
FRO
Founded
1998
1985
Country
United States
Cyprus
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
5.2B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
GKOS
FRO
Price
$116.08
$21.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
3
Target Price
$125.54
$28.67
AVG Volume (30 Days)
865.8K
3.5M
Earning Date
10-29-2025
11-21-2025
Dividend Yield
N/A
8.20%
EPS Growth
N/A
N/A
EPS
N/A
0.98
Revenue
$469,820,000.00
$1,766,241,000.00
Revenue This Year
$31.15
N/A
Revenue Next Year
$24.15
$20.53
P/E Ratio
N/A
$22.22
Revenue Growth
30.38
N/A
52 Week Low
$73.16
$12.40
52 Week High
$163.71
$26.00

Technical Indicators

Market Signals
Indicator
GKOS
FRO
Relative Strength Index (RSI) 76.42 34.85
Support Level $105.88 $22.35
Resistance Level $116.72 $23.10
Average True Range (ATR) 3.26 0.53
MACD 0.07 -0.16
Stochastic Oscillator 94.61 0.42

Price Performance

Historical Comparison
GKOS
FRO

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About FRO Frontline Plc

Frontline PLC is an international shipping company engaged in the seaborne transportation of crude oil and oil products. Group operates through the tankers segment. The tankers segment includes crude oil tankers and product tankers. Its geographical area of operation includes Arabian Gulf, West African, the North Sea, and the Caribbean. Frontline earns revenue through voyage charters, time charters, and a finance lease. It is also involved in the charter, purchase, and sale of vessels.

Share on Social Networks: